Axa S.A. Sells 18,666 Shares of CVS Health Corporation $CVS

Axa S.A. lowered its stake in CVS Health Corporation (NYSE:CVS) by 2.5% during the second quarter, Holdings Channel reports. The firm owned 732,229 shares of the pharmacy operator’s stock after selling 18,666 shares during the period. Axa S.A.’s holdings in CVS Health were worth $50,509,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CVS. Cantor Fitzgerald Investment Advisors L.P. raised its position in CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after purchasing an additional 6,615 shares in the last quarter. Brandywine Global Investment Management LLC raised its holdings in shares of CVS Health by 20.1% during the 1st quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after buying an additional 572,533 shares in the last quarter. Holderness Investments Co. bought a new stake in shares of CVS Health during the 1st quarter worth $300,000. Red Mountain Financial LLC acquired a new stake in CVS Health in the second quarter valued at about $293,000. Finally, AE Wealth Management LLC grew its position in CVS Health by 607.5% in the second quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock valued at $16,708,000 after acquiring an additional 207,984 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 2.3%

NYSE CVS opened at $78.31 on Wednesday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $99.41 billion, a PE ratio of 206.08, a price-to-earnings-growth ratio of 0.75 and a beta of 0.48. The business’s 50-day moving average price is $78.82 and its two-hundred day moving average price is $71.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period in the previous year, the firm earned $1.09 earnings per share. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s payout ratio is presently 700.00%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CVS shares. Morgan Stanley raised their price target on shares of CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a research note on Tuesday, October 14th. Jefferies Financial Group boosted their target price on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Mizuho increased their price target on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. The Goldman Sachs Group began coverage on CVS Health in a report on Tuesday, October 14th. They set a “buy” rating and a $91.00 price objective on the stock. Finally, Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.67.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.